Yixin H. Hou

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Fuzheng Huayu tablets reduces the risk of further decompensation after the first decompensation in patients with HBV-related cirrhosis: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.

Fuzheng Huayu tablets reduces the risk of further decompensation after the first decompensation in patients with HBV-related cirrhosis: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.

Journal: Frontiers in pharmacology

Published: March 23, 2026

A New Nomogram for Mortality Prediction Within 5 Years in Portal Vein Thrombosis due to Hepatitis B-Related Cirrhosis.

A New Nomogram for Mortality Prediction Within 5 Years in Portal Vein Thrombosis due to Hepatitis B-Related Cirrhosis.

Journal: Journal of viral hepatitis

Published: February 10, 2026

Prevotella-Derived Butyrate Inhibits CD8+ T-Cell Glycolysis via AKT/mTOR Signalling to Alleviate MASH.

Prevotella-Derived Butyrate Inhibits CD8+ T-Cell Glycolysis via AKT/mTOR Signalling to Alleviate MASH.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 10, 2025

Proteomics-based machine learning model for predicting secondary infection in HBV-related liver failure.

Proteomics-based machine learning model for predicting secondary infection in HBV-related liver failure.

Journal: Nature communications

Published: July 25, 2025

Controversy and consensus on antiviral treatment strategies for low-level hepatitis B surface antigens

Controversy and consensus on antiviral treatment strategies for low-level hepatitis B surface antigens

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: July 15, 2025

Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression.

Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression.

Journal: Alimentary pharmacology & therapeutics

Published: February 19, 2025

Machine Learning-Based Model Used for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.

Machine Learning-Based Model Used for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.

Journal: Journal of hepatocellular carcinoma

Published: October 21, 2024

An Integrated Analysis of the Role of Gut Microbiome-Associated Metabolites in the Detection of MASH-Related Cirrhosis.

An Integrated Analysis of the Role of Gut Microbiome-Associated Metabolites in the Detection of MASH-Related Cirrhosis.

Journal: Metabolites

Published: October 16, 2024

Nomograms for predicting short-term mortality in acute-on-chronic liver disease caused by the combination of hepatitis B virus and alcohol.

Nomograms for predicting short-term mortality in acute-on-chronic liver disease caused by the combination of hepatitis B virus and alcohol.

Journal: Scientific reports

Published: June 18, 2024

Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure.

Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure.

Journal: eGastroenterology

Published: May 31, 2024

Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study.

Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study.

Journal: OncoTargets and therapy

Published: October 13, 2023

The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution.

The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution.

Journal: Hepatology communications

Published: June 13, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026